Joey Studts, Ph.D.

Director, Late Stage Purification Development at Boehringer Ingelheim Pharma GmbH & Co. KG

Speaker

Dr. Joey Studts is currently Director of Downstream Development in the Innovation Unit of Boehringer Ingelheim Pharma GmbH in Biberach Germany. In this role, he is responsible for the development of purification processes for the production of therapeutic proteins for pre-clinical, clinical, and market supply. Dr. Studts has a strong focus on late-stage process development with experience in bringing innovative drugs to the market from a CMC perspective as well as implementing novel technologies in the fields of modeling, digital control strategies and PAT. Dr. Studts did a post-doctoral fellowship in the Department of Immunology at Washington University in St. Louis with Professor Daved Fremont, Ph.D. Joey received his Ph.D. under the guidance of Professor Brian G. Fox, Ph.D., at the Institute for Enzyme Research in the Department of Biochemistry at the University of Wisconsin at Madison after completing a B.S. in Chemistry at Loras College in Dubuque, IA, USA.